These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18985306)

  • 1. Neuroenhancement: status quo and perspectives.
    Normann C; Berger M
    Eur Arch Psychiatry Clin Neurosci; 2008 Nov; 258 Suppl 5():110-4. PubMed ID: 18985306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroenhancement strategies for psychiatric disorders: rationale, status quo and perspectives.
    Normann C; Nissen C; Frase L
    Eur Arch Psychiatry Clin Neurosci; 2012 Nov; 262 Suppl 2():S113-6. PubMed ID: 22932721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Options, limits and ethics of pharmacological neuroenhancement].
    Normann C; Boldt J; Maio G; Berger M
    Nervenarzt; 2010 Jan; 81(1):66-74. PubMed ID: 19851745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroenhancement and mood enhancement – Physiological and pharmacodynamical background.
    Weiergräber M; Ehninger D; Broich K
    Med Monatsschr Pharm; 2017 Apr; 40(4):154-64. PubMed ID: 29952165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacological neuroenhancement and brain doping : Chances and risks].
    Franke AG; Lieb K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Aug; 53(8):853-9. PubMed ID: 20700786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerating human evolution.
    Harris ED
    Pharos Alpha Omega Alpha Honor Med Soc; 2009; 72(3):1. PubMed ID: 19722297
    [No Abstract]   [Full Text] [Related]  

  • 7. Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories.
    de Jongh R; Bolt I; Schermer M; Olivier B
    Neurosci Biobehav Rev; 2008; 32(4):760-76. PubMed ID: 18295885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological Neuroenhancement: Current Aspects of Categorization, Epidemiology, Pharmacology, Drug Development, Ethics, and Future Perspectives.
    Daubner J; Arshaad MI; Henseler C; Hescheler J; Ehninger D; Broich K; Rawashdeh O; Papazoglou A; Weiergräber M
    Neural Plast; 2021; 2021():8823383. PubMed ID: 33519929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modern approaches to human cognitive activity enhancement].
    Zemlianaia AA; Fedotcheva TA; Fedotchev AI
    Usp Fiziol Nauk; 2010; 41(4):45-62. PubMed ID: 21254542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is caffeine a cognitive enhancer?
    Nehlig A
    J Alzheimers Dis; 2010; 20 Suppl 1():S85-94. PubMed ID: 20182035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of modafinil on learning performance and neocortical long-term potentiation in rats.
    Burgos H; Castillo A; Flores O; Puentes G; Morgan C; Gatica A; Cofré C; Hernández A; Laurido C; Constandil L
    Brain Res Bull; 2010 Oct; 83(5):238-44. PubMed ID: 20800665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Neuroenhancement in healthy subject? A French case study].
    Micoulaud-Franchi JA; Vion-Dury J; Lancon C
    Therapie; 2012; 67(3):213-21. PubMed ID: 22874487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive effects of methylphenidate in healthy volunteers: a review of single dose studies.
    Linssen AM; Sambeth A; Vuurman EF; Riedel WJ
    Int J Neuropsychopharmacol; 2014 Jun; 17(6):961-77. PubMed ID: 24423151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review.
    Battleday RM; Brem AK
    Eur Neuropsychopharmacol; 2016 Feb; 26(2):391. PubMed ID: 26708317
    [No Abstract]   [Full Text] [Related]  

  • 15. The Case of Pharmacological Neuroenhancement: Medical, Judicial and Ethical Aspects from a German Perspective.
    Franke AG; Northoff R; Hildt E
    Pharmacopsychiatry; 2015 Nov; 48(7):256-64. PubMed ID: 26252723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Author׳s response on "Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review".
    Battleday RM; Brem AK
    Eur Neuropsychopharmacol; 2016 Feb; 26(2):394-395. PubMed ID: 26718790
    [No Abstract]   [Full Text] [Related]  

  • 17. Correspondence arising: Modafinil for cognitive neuroenhancement in health non-sleep-deprived-subjects.
    Repantis D; Maier LJ; Heuser I
    Eur Neuropsychopharmacol; 2016 Feb; 26(2):392-393. PubMed ID: 26706695
    [No Abstract]   [Full Text] [Related]  

  • 18. Correspondence arising: Modafinil for cognitive neuroenhancement in health non-sleep-deprived-subjects.
    Nicholson PJ
    Eur Neuropsychopharmacol; 2016 Feb; 26(2):390. PubMed ID: 26706693
    [No Abstract]   [Full Text] [Related]  

  • 19. Social cognition.
    Patin A; Hurlemann R
    Handb Exp Pharmacol; 2015; 228():271-303. PubMed ID: 25977087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropharmacological basis of stimulant drug action in attention deficit disorder with hyperactivity: a review and synthesis.
    Solanto MV
    Psychol Bull; 1984 May; 95(3):387-409. PubMed ID: 6152684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.